Valuation: Divi's Laboratories Limited

Capitalization 1,78100Cr 1.89TCr 1.6TCr 1.47TCr 1.38TCr 2.58TCr 2.6TCr 17TCr 6.78TCr 86TCr 7.08TCr 6.93TCr 2,95400Cr P/E ratio 2026 *
69.5x
P/E ratio 2027 * 57.7x
Enterprise value 1,74800Cr 1.85TCr 1.57TCr 1.44TCr 1.36TCr 2.53TCr 2.56TCr 17TCr 6.65TCr 84TCr 6.94TCr 6.8TCr 2,89800Cr EV / Sales 2026 *
16.4x
EV / Sales 2027 * 14.1x
Free-Float
47.96%
Yield 2026 *
0.5%
Yield 2027 * 0.55%
1 day+0.12%
1 week+3.20%
Current month+3.20%
1 month+12.73%
3 months+9.77%
6 months+0.81%
Current year+4.97%
1 week 6,483.5
Extreme 6483.5
6,780
1 month 5,970
Extreme 5970
6,780
Current year 5,647.5
Extreme 5647.5
6,793
1 year 5,636.5
Extreme 5636.5
7,071.5
3 years 3,051
Extreme 3051
7,071.5
5 years 2,730
Extreme 2730
7,071.5
10 years 532.65
Extreme 532.65
7,071.5
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Change 5d. change 1-year change 3-years change Capi.($)
+0.12%+3.20%+11.37%+98.35% 1.89TCr
-2.72%-1.54%+29.12%+121.40% 85TCr
-0.53%-2.58%+43.51%+37.42% 53TCr
-0.57%-2.44%+9.18%+37.27% 36TCr
-0.94%-0.97%+22.40%+11.18% 32TCr
+0.23%-1.24%+30.31%+12.00% 28TCr
+0.05%-2.19%+24.69%+21.29% 28TCr
-0.82%-0.70%+46.61%-5.15% 28TCr
-1.76%+4.42%-34.66%-49.15% 20TCr
+0.79%+0.57%+24.76%+41.49% 18TCr
Average -0.62%-0.35%+20.73%+32.61% 32.94TCr
Weighted average by Cap. -1.05%-1.24%+25.56%+44.54%

Financials

2026 *2027 *
Net sales 11TCr 112.72Cr 96Cr 88Cr 83Cr 154.31Cr 155.67Cr 1.04TCr 405.29Cr 5.11TCr 422.9Cr 414.01Cr 18TCr 12TCr 130.9Cr 111.21Cr 101.78Cr 96Cr 179.19Cr 180.77Cr 1.21TCr 470.63Cr 5.94TCr 491.09Cr 480.76Cr 21TCr
Net income 2.56TCr 27Cr 23Cr 21Cr 20Cr 37Cr 37Cr 249.82Cr 97Cr 1.23TCr 101.62Cr 99Cr 4.24TCr 3.09TCr 33Cr 28Cr 25Cr 24Cr 45Cr 45Cr 301.94Cr 117.7Cr 1.49TCr 122.82Cr 120.24Cr 5.13TCr
Net Debt -3.38TCr -36Cr -30Cr -28Cr -26Cr -49Cr -49Cr -330.41Cr -128.8Cr -1.63TCr -134.4Cr -131.57Cr -5.61TCr -3.67TCr -39Cr -33Cr -30Cr -29Cr -53Cr -54Cr -358.34Cr -139.69Cr -1.76TCr -145.76Cr -142.7Cr -6.08TCr
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
10,542
Date Price Change Volume
08/26/08 6,710.50 +0.12% 1,55,071
07/26/07 6,702.50 +0.01% 3,30,052
06/26/06 6,702.00 +0.77% 3,14,250
05/26/05 6,651.00 +0.48% 1,95,449
04/26/04 6,619.50 +1.80% 3,71,945
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
6,710.50INR
Average target price
6,876.70INR
Spread / Average Target
+2.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. DIVISLAB Stock